Monday, 7 October
Afternoon
Tuesday, 8 October
Morning
Afternoon
Wednesday, 9 October
Morning
Afternoon
Thursday, 10 October
Morning
Afternoon
Friday, 11 October
Morning
Afternoon
Afternoon
Morning
Afternoon
Morning
Afternoon
Morning
Afternoon
Morning
Afternoon
08:30 - 16:30
Good Manufacturing Practice (GMP)*

As part of a quality management system, the guidelines for Good Manufacturing Practice (GMP) shall constantly ensure appropriate quality standards upon production and quality control of products as required by the Marketing Authorisation, Clinical Trial Authorisation or product specification.
Contents of the GMP course:

  • Patient Safety
  • Key Requirements
  • Good Documentation Practice
  • Operational Hygiene
  • Calibration – Qualification – Validation
  • GMP in Cell Culture and Fermentation
  • GMP for Advanced Therapy Medicinal Products (ATMP)

The EBW2019 Steering Committee reserves the right to cancel the course if registrations do not reach the minimum required number.

08:30 - 16:30
Good Laboratory Practice (GLP)*

The guidelines for Good Laboratory Practice (GLP) provide an international quality standard for planning, performing, monitoring, recording, archiving and reporting non-clinical health and environmental safety studies. Application of this quality system shall provide comparable quality of test data around the world in order to protect human health as well as the environment, to avoid duplicative testing, and to remove barriers to global trade.
Contents of the GLP course:

  • Regulatory Background: legal requirement (must have) or voluntary use (nice to have)
  • Organisation and Personnel
  • Facilities, Apparatus, Working Procedures
  • Planning, Performing and Reporting GLP-studies
  • Compliance Monitoring Authorities

The EBW2019 Steering Committee reserves the right to cancel the course if registrations do not reach the minimum required number.

08:30 - 16:30
Good Clinical Practice (GCP)*

The guidelines for Good Clinical Practice (GCP) provide an international quality standard for designing, conducting, recording and reporting clinical trials that involve human subjects under ethical and scientific considerations. The guideline shall ensure that rights, safety and well-being of trial subjects are met with respect to the Declaration of Helsinki. Furthermore, it provides reassurance on the integrity of trial data.
Contents of the GCP course:

  • Definitions and terminology (13 principles)
  • Responsibilities of the ethics committee
  • Responsibilities of investigators
  • Responsibilities of sponsors/monitors
  • Essential documents: when to collect and where to file
  • ICH-GCP
  • Real life cases

The EBW2019 Steering Committee reserves the right to cancel the course if registrations do not reach the minimum required number.

08:30 - 16:30
IATA Training (in German)*

The IATA (International Air Transport Association) certified course is a full-day training concerning the shipment of diagnostic samples on dry ice. Training material, exam and certificates are included.

Contents of the IATA Training course:

  • legal basis (international, national)
  • dangerous goods classes (especially class 6.2, dry ice, liquid nitrogen)
  • identification and working with the list of dangerous goods
  • packaging requirements for UN3373 and dry ice
  • marking and labelling of packages
  • responsibilities and training requirements
  • other persons involved in air traffic (e.g. regulations for passengers)
  • final exam

The EBW2019 Steering Committee reserves the right to cancel the course if registrations do not reach the minimum required number.

13:30 - 16:30
Guided Tour of Lübeck Biobank, University Hospital & Fraunhofer EMB for Marine Biotechnology**

The three-hour Campus tour will comprise visits to (i) the Interdisciplinary Center for Biobanking-Lübeck (ICB-L), (ii) the new central hospital building of the University Hospital Schleswig-Holstein (UKSH), and (iii) the Fraunhofer Research Institute for Marine biotechnology.

More information

 

Courtesy of

17:00 - 18:30
Sightseeing Tour Lübeck*

Do you want to travel through time and listen to stories? Guides, dressed in historical costumes, talk about the customs and traditions of their time: either the middle ages or the 19th century. Come and experience Lübeck’s charm, join us on our walk to the city’s sights on the island of the old town, which measures about two square kilometres.

We will visit the world-famous medieval buildings from Lübeck’s heyday as the queen of the Hanseatic League – the Holsten Gate, St. Mary’s church or the Buddenbrook house.

Registration is required. The EBW2019 Steering Committee reserves the right to cancel the tour(s) if registrations do not reach the minimum required number.

18:00 - 21:00
University of Lübeck & UKSH Welcome Reception*

The University of Lübeck invites all EBW2019 attendees to a Welcome Reception at the St. Petri Church starting at 18:00. The over 800-year-old church is now used by the University of Lübeck to interconnect with the Lübeck population, encourage networking within a spiritual atmosphere and promote critical discussions and reflections on challenges of modern societies.

The scenic view platform of St. Petri’s Tower will be open for the registered attendees and guarantees a splendid orientation and view over the medieval city of Lübeck.

The University of Lübeck will wholeheartedly welcome you at 19:00 with a welcome note followed by classical music, welcome drinks and light bites.
Registration is required.

Courtesy of

08:00 - 18:00
Registration
09:00 - 12:00
Workshop 4: Opportunities and Challenges to Implement the New Biobank Standard*

In order to obtain reliable and replicable scientific results on human biomaterials, well characterized, high-quality biosamples and the corresponding data are required. These can only be achieved through the implementation of sophisticated quality measures.
International management standards (ISO 9001) and industry-specific standards (ISO 17025/17020) support professionals. In August 2018, the international biobank specific standard ISO 20387 was published to explicitly reflect the specific requirements for the competence of biobanks. Based on the general requirements of this standard, technical specifications and sub-standards (e.g. ISO 20388, 20389) as well as the corresponding “Technical Report” were developed as practical implementation aids. The national accreditation authorities endeavour to facilitate accreditation according to ISO 20387 as quickly as possible.
During the workshop, the content and scope of the applicable standards will be discussed and the consequences and advantages for biobanks will be presented. Participants will gain insights into already established measures and instruments for the implementation of an appropriate quality management system in biobanks. Two different European countries will showcase state-of-the-art examples for the national implementation of the requirements in practice and participants will have the opportunity to talk to the experts from BBMRI-ERIC, ESBB and the German Biobank Alliance.
The workshop will be focused on the following:
PART 1: Overview of applicable standards – in particular ISO 20387, current status, related standards and regulations
PART 2: Measures and tools provided by BBMRI-ERIC and ESBB: How to improve quality management in biobanks
PART 3: Best practice examples – How to apply the biobanking standard from the ESBB and German Biobank Alliance/BBMRI-ERIC perspective.
Organizers:
Sabrina Schmitt, BioMaterialBank Heidelberg, Germany
Andrea Wutte, BBMRI-ERIC Headquarter
Bettina Meinung, Biobank Jena
Ayat Salman, McGill University Health Centre

09:00 - 12:00
Workshop 1: Automated Sample Storage and IT Solutions – Are We There Yet and Is It Worth It?*

Modern and high-quality biobanking is based on high-quality samples and high-quality data. This is why more and more biobanks are moving in the direction of automated sample processing and storage. While automated sample processing is no longer indispensable, the automated storage process has different and more complicated challenges to address: starting with (ultra)low-temperature-related issues, like icing, leading to long installation times and high maintenance of the systems, all the way to high costs and technical challenges. Still, many biobanks believe in this young technology and put up with it, especially in the context of automated data transfer to their biobank management systems. Nevertheless, issues to consider for every biobank include cost- and time-efficiency and possible set-ups under consideration of their own site, e. g. data transfer within and outside of the clinic network.
The workshop will be focused on the following:
PART 1: Automated storage at -80°C & Automated nitrogen storage
PART 2: Roundtable with vendors
PART 3: Biobank hands-on
This workshop will address the technical progress and the ongoing improvements regarding automated (ultra)low-temperature storage under consideration of implemented data transfer trying to determine whether an investment is feasible and advisable.
Organizers:
Lena Figge, Interdisciplinary Center for Biobanking-Lübeck, Lübeck, Germany
Manon Huizing, Antwerp University Hospital, Antwerp, Belgium
James Thompson, Karolinska Institutet, Sweden
Speakers:
Bartlomiej Wilkowski, Danish National Biobank, Copenhagen
Erik Sattler, Danish National Biobank, Copenhagen
Tanja Weis, Heidelberg CardioBiobank, Heidelberg, Germany
Trine Govasli Altø, HUNT Biobank, Levanger, Norway
Norman Klopp, Hannover Unified Biobank, Hanover, Germany
Tanja Fröhlich, Biobank Bern, Bern, Switzerland
Friedemann Flügge, Interdisciplinary Center for Biobanking-Lübeck, Lübeck, Germany

09:00 - 12:00
Workshop 3: Communication Strategies for Science and Networks – Create and Foster a Biobanking Community on Social Media (upon invitation only)*

Biobanks are becoming more and more important: personalised medicine cannot be delivered without high-quality and connected biobanks. The steadily growing duty to communicate biobanks’ activities within our communities and to patients’ organisations and the larger public is a challenge faced by all research infrastructures.
The workshop will provide a participants with communication best practices and experience from the biobanking world and a hands-on training on the use of social media in science communication and dissemination. The workshop is aimed at communication staff with beginner to advanced social media experience. This year we are limiting participation to ensure that participants get the most out of this opportunity.
The external keynote speaker will share their experience in an interactive way, exploring social media as the main communication channel and platform to build a biobanking community. The custom-made social media workshop will emphasize how to manage your on-line presence, from the ins and outs of storytelling, to providing social media tips and tricks which will help you connect with influencers and EU policy makers.
Organizer: Jon Worth

09:00 - 12:00
Workshop 2: IT Challenges and Solutions for Biobanks*

The focus of the workshop is on national and international biobank networks and the technological future orientation in the field of biobanks. After a brief introduction to the current biobank registers, the workshop will explain how biobanks can participate in these networks. The advantages of such participation will be illustrated. The German Biobank Alliance will present an initiative for the standardization of sample data in the latest HL7 standard FHIR.
The second part starts with a report of trends in biobanking and raises the question if biobanks will act more as a data provider than sample provider in the near future. Subsequently, we invite companies to demonstrate the different product philosophies and functionalities of their software in the field of linking research and sample data using a practical example under comparable conditions. In a biobanking slam, selected visions of the future will be presented briefly and boldly.
Organizers:
Petra Duhm-Harbeck, IT Center for Clinical Research, Lübeck, Germany
Ann-Kristin Kock-Schoppenhauer, IT Center for Clinical Research, Lübeck, Germany
Petr Holub, BBMRI-ERIC
Moderator:
Ulrich Prokosch, Chair of Medical Informatics, Friedrich-Alexander-University Erlangen-Nürnberg, CIO, Erlangen University Hospital, Germany
Speakers:
Petr Holub, BBMRI-ERIC | How to Participate in National and International Biobank Registries and What Are the Benefits from an IT Perspective?
Anni Ahonen Bishopp, BC Platforms | How to Participate in National and International Biobank Registries and What Are the Benefits from an IT Perspective?
Noemi Deppenwiese | Biobanks on FHIR
Dr. Björn Kroll | Biobanks on FHIR
TBC | Biobank Trends: Shifting from Sample to Data Provision and More…
TBC | Research Data Documentation: How to Handle Raw Research Data and Linking Them to Sample/Patient Information
TBC | Biobanking Slam: Future Technologies

12:00 - 12:30
Lunch
12:30 - 13:30
WG ESBB Africa***

The ESBB Working Group meetings at the EBW2019 will be open for non-ESBB members as well, but only by registering. The ESBB WG meetings will reflect on the work conducted during the last year as well as on the WG’s current tasks and discuss future topics to be addressed. Further details per Working Group will follow shortly.

12:30 - 13:30
WG ESBB Automation & Interfaces !NEW!***

The ESBB Working Group meetings at the EBW2019 will be open for non-ESBB members as well, but only by registering. The ESBB WG meetings will reflect on the work conducted during the last year as well as on the WG’s current tasks and discuss future topics to be addressed. Further details per Working Group will follow shortly.

12:30 - 17:30
BBMRI-ERIC CS ELSI Team Meeting (upon invitation only)

This is the annual face to face team meeting of the BBMRI-ERIC Common Service ELSI. A detailed agenda will be provided to the ELSI team members directly.

12:30 - 13:30
WG ESBB Social Media***

The ESBB Working Group meetings at the EBW2019 will be open for non-ESBB members as well, but only by registering. The ESBB WG meetings will reflect on the work conducted during the last year as well as on the WG’s current tasks and discuss future topics to be addressed. Further details per Working Group will follow shortly.

13:30 - 14:30
WG ESBB Regulatory, Ethics & GDPR !NEW!***

The ESBB Working Group meetings at the EBW2019 will be open for non-ESBB members as well, but only by registering. The ESBB WG meetings will reflect on the work conducted during the last year as well as on the WG’s current tasks and discuss future topics to be addressed. Further details per Working Group will follow shortly.

13:30 - 14:30
WG ESBB Patient Outreach***

The ESBB Working Group meetings at the EBW2019 will be open for non-ESBB members as well, but only by registering. The ESBB WG meetings will reflect on the work conducted during the last year as well as on the WG’s current tasks and discuss future topics to be addressed. Further details per Working Group will follow shortly.

13:30 - 14:30
WG ESBB Education & Training***

The ESBB Working Group meetings at the EBW2019 will be open for non-ESBB members as well, but only by registering. The ESBB WG meetings will reflect on the work conducted during the last year as well as on the WG’s current tasks and discuss future topics to be addressed. Further details per Working Group will follow shortly.

14:30 - 15:30
ESBB General Assembly***
15:30 - 16:30
WG ESBB Environment & Human Biomonitoring !NEW!***

The ESBB Working Group meetings at the EBW2019 will be open for non-ESBB members as well, but only by registering. The ESBB WG meetings will reflect on the work conducted during the last year as well as on the WG’s current tasks and discuss future topics to be addressed. Further details per Working Group will follow shortly.

15:30 - 16:30
WG ESBB Agriculture & Plants !NEW!***

The ESBB Working Group meetings at the EBW2019 will be open for non-ESBB members as well, but only by registering. The ESBB WG meetings will reflect on the work conducted during the last year as well as on the WG’s current tasks and discuss future topics to be addressed. Further details per Working Group will follow shortly.

15:30 - 16:30
WG ESBB Science & Innovation***

The ESBB Working Group meetings at the EBW2019 will be open for non-ESBB members as well, but only by registering. The ESBB WG meetings will reflect on the work conducted during the last year as well as on the WG’s current tasks and discuss future topics to be addressed. Further details per Working Group will follow shortly.

16:30 - 17:30
WG ESBB Domestic & Wildlife Animals !NEW!***

The ESBB Working Group meetings at the EBW2019 will be open for non-ESBB members as well, but only by registering. The ESBB WG meetings will reflect on the work conducted during the last year as well as on the WG’s current tasks and discuss future topics to be addressed. Further details per Working Group will follow shortly.

16:30 - 17:30
WG ESBB Academic & Industry Cooperation***

The ESBB Working Group meetings at the EBW2019 will be open for non-ESBB members as well, but only by registering. The ESBB WG meetings will reflect on the work conducted during the last year as well as on the WG’s current tasks and discuss future topics to be addressed. Further details per Working Group will follow shortly.

16:30 - 17:30
WG ESBB Data Standardization & Harmonization***

The ESBB Working Group meetings at the EBW2019 will be open for non-ESBB members as well, but only by registering. The ESBB WG meetings will reflect on the work conducted during the last year as well as on the WG’s current tasks and discuss future topics to be addressed. Further details per Working Group will follow shortly.

18:00 - 22:00
Young Biobankers Night: Personal Development and Career Planning*

In a relaxed atmosphere, questions relating to personal development and career opportunities in the field of biobanking will be discussed among our Young Biobankers. Get in touch with other Young Biobankers and talk about your goals, wishes and career opportunities and challenges. Registered attendees will be asked to fill out a questionnaire online before EBW2019 takes place. This might be a basis for further discussions face-to-face and can potentially be developed into a “white paper” to be discussed with Advanced Biobankers, authorities and stakeholders. The Young Biobankers night will take place in the Cafe & Bar Celona located at the Lübeck harbor front with a beautiful view of the old town. By registering, you will get a seat reserved by EBW2019, but food and beverages are bought at your own cost.

Meeting Point:
Cafe & Bar Celona Lübeck
Hafenstraße 1
23568 Lübeck

18:00 - 22:00
Advanced Biobankers Night: Strategic Alliances & Networks for Biobanks*

In one of Lübeck’s oldest buildings in the old town, Advanced Biobankers will meet in a relaxed atmosphere to strengthen existing and build new networks and strategic alliances. Opportunities and challenges to further promote biobanking and sustain our services and goals will be discussed, among other topics.
By registering, you will get a seat reserved by EBW2019, but food and beverages are bought at your own cost.

Meeting Point:
Schiffergesellschaft
Breite Straße 2
23552 Lübeck

08:00 - 18:00
Registration
09:00 - 10:30
Opening Ceremony
10:30 - 11:00
Coffee Break – Exhibition – Poster Viewing
11:00 - 12:30
Biobanking for Precision Medicine

Biobanks are essential for scientific breakthroughs in precision medicine leading to new treatments. Precision medicine research is based on the analysis of samples with clinical data – and, because the associations are often weak, we need these samples in large quantities. The implication is clear: if more, well-characterized, high-quality samples are available through biobanks, the faster research will advance and impact upon the faster delivery of precision healthcare today. The systematic collection of human samples of high quality is a key element for the success of future treatments. Furthermore, biobanks are already part of molecular tumor board process chains thus improving patient treatment individually. During this session, we will show examples and discuss how biobanks can facilitate and improve precision medicine now and in the future.
Session Chairs: Jens Habermann & Anu Jalanko

12:30 - 14:00
Lunch – Exhibition
12:30 - 13:30
Cooperate Workshops
13:00 - 13:30
11A: Pitch Your Innovative Idea

Innovative idea pitches – 5-minute presentations. These could be cutting-edge ideas, products, or solutions that could impact samples, biobankers, researchers and patients, and eventually add to a healthier world. The floor is open for all stakeholders, from biobankers to vendors, from researchers to patients.
Session Chairs: Jens Habermann & Erik Steinfelder

13:00 - 14:00
Vendor Tour*
14:00 - 15:30
3A: Pre-Analytic Impact on Sample Quality – Means & Measures

The emerging ISO standards for the pre-analytical handling of samples in biobanking give hope that sample quality can be much better maintained and documented. The aim of the session is to focus on the problem of reproducibility by examining where in modern biobanking variability occurs and how we can diminish these issues in the future in order to drive the quality of the biobank samples forward and to be ready for the demand for high-quality samples for all novel technologies.
Session Chairs: Dr Ronny Baber & Michael Hisbergues
Speakers:
Patrick Pauwels
Michael Kiehntopf

14:00 - 15:30
3B: Academic-Industrial Partnerships for a Healthier World

In order to advance research and development, there is a need for collaborations between academia, industry, government agencies, and private partners. These consortia have the potential to solve major medical and public health issues if they can set terms and goals that reward all parties. In this session, we will focus on the potential and obstacles of academic-industrial partnerships by showcasing examples such as public-private partnerships, IMI projects, Expert Centers, and more.
Session Chairs: Phil Quinlan & Rolf Morselt

14:00 - 15:30
3C: Rare Diseases: The Next Big Step

Biobanking is highly critical to advance research in rare diseases. The aim of the session is to showcase how obstacles are overcome for rare disease cohorts, despite rarity and diversity.
Session Chairs: Sofie Bekaert & Gulcin Gumus
Speakers:
Marie Wang | Overcoming Rarity and Diversity: Rare Disease Biobanking State-of-Art

14:00 - 15:30
3D: Wildlife Biobanking to Preserve Biodiversity of Endangered Species

This session will showcase and discuss (i) the role of biobanks in new conservation strategies for saving extremely endangered species from extinction and (ii) biobanks as new source for studying evolutionary traits on the cellular level in different species and their biomedical potential for developing new treatment strategies for example against cancer, diabetes or cardiovascular diseases.
Session Chairs: Thomas Hildebrandt & Oliver Ryder
Speakers:
Thomas Hildebrandt | Advanced Assisted Reproduction Technologies (aART) and Stem Cell Associated Techniques (SCAT) for Saving Critically Endangered Rhinoceros Species
Oliver Ryder | Viable Tissue Culture Cell Cryobanks Are Urgently Needed to Conserve Biodiversity and Provide Options for Preventing Species Extinctions

15:30 - 16:00
Coffee Break – Exhibition – Poster Viewing
16:00 - 17:00
Poster Session I
17:00 - 18:30
4A: Harmonisation and Standardisation: What Is Needed, What Is Possible?

Implementation of the newly published CEN technical specifications and the new ISO standards on biobanks (ISO TC276), which describe requirements of standardization and documentation, is a crucial step toward better reproducibility of results. In this session, we will discuss the opportunities of these standards and the hurdles to overcome when implementing these standards. We also highlight implementation programs or projects as examples of how to put these standards into practice.
Session Chairs: Dr. Nahla Afifi & Dalibor Valik

17:00 - 18:30
4B: Oxford Style Debate

Session Chairs: Ayat Salman & Francesco Florindi

17:00 - 18:30
4C: IT Solutions for Data and Sample Sharing

To make the samples of biobanks visible to the research community, biobank IT solutions such as catalogues are built. However, many questions remain as to how one can build IT solutions that are fit for purpose for the demanding needs of future research. How do you build IT solutions that are interoperable with other existing IT solutions? Which minimal data should be included? How can you improve the design and implementation of your catalogue? In this session, experiences from IT solutions established in different geographical regions, networks, and consortia, and their utility will be presented. The discussions will include how the IT solutions are (or are not) operating to provide visibility and facilitate utility of available samples and data for research.
Session Chairs: Michael Hummel & Mark Divers

17:00 - 18:30
4D: Zoo Biobanking to Preserve & Protect Endangered Species

Zoos play a fundamental role in protecting and preserving endangered species. Particularly, zoological research centers address genetics, animal behaviour, animal welfare, veterinary medicine and animal morphology, among other topics. Hereby, biobanks enable local and international collaborative research projects addressing sample quality, traceability, transparency and exchangeability. This session will showcase successful zoological research projects while indicating current and future challenges and discussing possible solutions.
Session Chairs: Christina Hvilsom & Philipp Ciba
Speakers:
Christina Hvilsom

18:30 - 21:00
Welcome Reception*
08:00 - 18:00
Registration
09:00 - 10:30
5B: Quality Assessment & Management of Sample

Quality assessment and management of samples is a critical aspect in biobanking since the consistent quality of biospecimens is necessary to generate reliable data for basic and clinical research. This session will aim to provide up-to-date approaches to assess the quality of your samples and examples of quality management programs available to support this.
Session Chairs: Andrea Wutte & Loes Linsen
Speakers:
Uwe Oelmüller

09:00 - 10:30
5C: Is Your Biobank Healthy?

How do you create and sustain a healthy biobank? In this session we present and discuss how you can improve the financial, operational and social sustainability of biobanks.
Session Chairs: Kirstin Goldring & Andres Metspalu
Speakers:
Erik Steinfelder

09:00 - 10:30
5D: TMF Satellite Meeting

Session Chair: Sebastian Semmler
Speakers:
Michael Kiehntopf
Sebastian Semmler

09:00 - 10:30
5A: 500 Days into the GDPR

This session focuses on the implications of the General Data Protection Regulation (GDPR) for our biobanking community, especially the impact of the national derogations and the intrinsic issues faced by biobanks and research in relation to the requirements of data processing, including transnational transfer, transfer to third countries, and secondary use of data. We welcome presentations that highlight the challenges and solutions (best practices) implementing the legal requirements.
Session Chairs: Victoria Chico & Rosita Kammler
Speakers: 
Rita Lawlor

10:30 - 11:00
Coffee Break – Exhibition – Poster Viewing
11:00 - 12:30
Environment, Biodiversity and Human Health

Environmental monitoring is used in the preparation of environmental impact assessments, as well as in many circumstances in which human activities carry a risk of harmful effects on the natural environment. Environmental monitoring data are collected and used as science-based evidence to underpin measures for safeguarding the environmental quality and to minimize the adverse effects of stressors on the environment and human health. Biomonitoring, the monitoring of chemicals in the environment, serves as the basis for a wide range of political decisions and regulatory measures in the field of environmental health. Biobanks play a key role in assessing environmental healthiness since they can provide high-quality environmental samples with associated data. Hence, the aim of this session is to highlight the general value of biobanks for environmental monitoring by providing insights into the latest research results and initiating a joint discussion on how established and internationally distributed biobanks can work together, how samples can be shared, and how to create the greatest possible knowledge by collaborating to monitor pollution and its effect on the environment.
Session Chairs: Alex Felice & Dominik Lermen
Speakers:
Jan Koschorrek

12:30 - 13:30
Cooperate Workshops
12:30 - 14:00
Lunch – Exhibition
13:00 - 13:30
11B: Pitch your Innovative Idea

Innovative idea pitches – 5-minute presentations. These could be cutting-edge ideas, products, or solutions that could impact samples, biobankers, researchers and patients, and eventually add to a healthier world. The floor is open for all stakeholders, from biobankers to vendors, from researchers to patients.
Session Chairs: Jens Habermann & Erik Steinfelder

13:00 - 14:00
Vendor Tour*
14:00 - 15:30
7C: Cryobiology – What Biobankers Should Know (GDK)

Session Chairs: Johannes Schenkel & Andreas Hörlein
Speakers: Johannes Schenkel & Andreas Hörlein

14:00 - 15:30
7A: How do Biobanks Support Clinical Trials & Precision Medicine?

The quest to personalized medicine leads to very complicated scientific questions in clinical trials, demanding even further refinement of corresponding clinical information. Having good samples and data for translational research is fundamental to personalized medicine. Fit for purpose biobanks can drive efficient, effective and high-quality delivery of new medicines, improving the health of people around the world. In this session, we will showcase how biobanks can support clinical trials to find answers needed to make precision medicine available for all patients.
Session Chairs: Christine Currat & Rita Lawlor
Speakers:
Carlo Largiadèr | Health-Care Integrated Biobanking Processes to Support Precision Medicine Clinical Trials

14:00 - 15:30
7D: Maintenance of High Plant Tissue Viability – Challenges in the Quality Management of Plant Biobanks

Plant biobanks, such as in vitro gene banks, plant cryobanks, seedbanks for crops and wild species, field gene banks and collections of plant cell cultures and algae, preserve valuable genetic resources. To maintain high quality and viability of plant tissues are the major challenges. The presentations in the sessions will focus on challenges, milestones and critical aspects of the quality management of plant genetic resources.
Session Chairs: Manuela Nagel & Elena Popova
Speaker: Elena Popova

14:00 - 15:30
7B: Quality Assessment and Management of Data

If we want researchers to be able to produce reliable findings, we need to make sure that they have access not only to high-quality samples but also to associated high-quality data. In this session, we will present the state-of-the-art in data quality: the definition of data quality, the dimensions of data quality, and quality management systems for achieving or describing the aspired data quality characteristics.
Session Chairs: Georg Göbel & Jeanne-Hélène di Donato

15:30 - 16:00
Coffee Break – Exhibition – Poster Viewing
16:00 - 17:00
Poster Session II
17:00 - 18:00
8A: Hospital Based Biobanks

Hospital-based biobanks collect biological material of healthy and/or diseased people and associated data. Implementing biobanks into a clinical routine is challenging due to many different requirements but offers tremendous possibilities for clinical trials and precision medicine. By integrating health datasets available in the hospitals, biobanks can raise the value of their data while opening new paths and potential for research. In this session, we will show examples from a variety of hospital-based biobanks throughout the world, the difficulties they are facing and the opportunities that these biobanks offer on the road to personalized medicine.
Session Chairs: Lukasz Kozera & Carlo Largiadèr
Speakers:
Kimmo Pitkänen
Janet Olsen

17:00 - 18:00
8B: Novel Molecular & Medical Imaging Technologies in Biobanking

Biobanks exceedingly extend their repertoire by characterizing biosamples through molecular imaging technologies and by implementing medical imaging data. This session will showcase and discuss the future impact and role of micro- / nanoscopy techniques and medical imaging for biobanks now and in the future. Molecular imaging technologies will include e.g., high-throughput tissue microarrays, live-cell microscopy, Total Internal Reflection Fluorescence (TIRF)-Microscopy, Stimulated Emission Depletion (STED)-nanoscopy, and Atomic Force Microscopy (AFM). Medical imaging tools will compromise a wide range of state-of-the-art clinical applications, e.g. Radiography, MRI, PET, SPECT, CT, and Magnetic Particle Imaging.
Session Chairs: Peter Riegman & Daniel Bos
Speakers:
Thorsten Buzug

17:00 - 18:00
8C: IVD, GMP & Cell Therapies: New Service Opportunities for Biobanks?

Cell therapies and/or gene therapies used in regenerative-, inflammatory-, autoimmune-, and/or oncology medicine require high-quality samples, standardised processing and secure sample and data logistics – fundamental assets of state-of-the-art biobanks. Similar requirements come with the new IVD regulations and confront (companion) diagnostic companies with new challenges. Overall, clinical applications afford higher regulatory levels than for research purposes and entail e.g., accreditations and GMP conformity. We invite you to showcase biobanks applying cell/gene therapies and to discuss future opportunities for biobanks through GMP and IVD regulations.
Session Chairs: Radka Kaneva & Michael Kiehntopf
Speakers:
Emilie Robert

17:00 - 18:00
8D: Introduction of Modern Technologies to Preserve Crops and Endangered Plant Species Efficiently

Plant biobanks are responsible for the maintenance of plant genetic diversity. The high variability within the species limits the possibility to apply standardized methods known from industry and agriculture, such as harvest, cleaning and controlling processes. Modern technologies, such as imaging technologies and machine learning approaches may face the challenge of the phenotypic variability of the different species. The presentations in the sessions will focus on the present and modern technologies and methodologies which increase the efficiency of processes and the quality of biobank material.
Session Chairs: Manuela Nagel & Elena Popova
Speakers: Fiona R. Hay | Seed Quality Management: Improving Operations at the International Genebanks

18:30 - 00:00
EBW Evening (Networking Dinner)*

All aboard and anchors aweigh! The historical atmosphere of the Hanseatic League can be felt in every corner of the city of Lübeck, but especially at the edge of the historic old town – in the city harbour. The EBW Evening, the prime networking occasion of the conference, will be held at the Schuppen 9, featuring an enchanting view of the Trave River and the old town, in vicinity of the European Hansemuseum. Built in 1906, Schuppen 9 impresses with its extraordinary interior, exuding a nautical feeling. Join us for a fabulous evening full of music, entertainment and excellent food, where modern day and tradition meet and mix.

Meeting Point: An der Untertrave 1a, 23552 Lübeck, Germany

08:00 - 18:00
Registration
09:00 - 10:30
9A: Ethics Café: What Now?

The format of an Ethics Café provides an opportunity to share views on specific topics in an informal setting. Consequently, no powerpoints allowed. The debate is kick-started by a provocative statement or engaging talk. The audience is invited to share thoughts and provide new insights for ultimately thought-provoking dialogue.
Session Chairs: Michaela Mayrhofer & Roland Jahns

09:00 - 10:30
9B: Museum Biobanking to Preserve and Protect Cultural Heritage

Museums prepare, digitise, analyse and interpret natural history materials reflecting the entire biodiversity from Earth and space. Biobanking has become an integral part of this endeavour. Successful projects will be highlighted and future challenges and possible solutions discussed.

10:30 - 12:00
Brunch – Exhibition
10:30 - 12:00
Cooperate Workshops
11:00 - 12:00
Vendor Tour*
12:00 - 13:30
10A: Future-Proof Sample and Data Access

How do biobanks govern sample and data access? The critical role of biobank access committees will be showcased, whether that is related to the scientific assessment of the research or the ethics review.
These are committees that are charged to ensure that samples and data are shared for sound scientific research.
This session is also open to other relevant ELSI issues related to sample and data access including the potential of stakeholder engagement in both the setup of a research project, and also in the conduct of the research project itself, such as the return of results of these research projects.
Session Chairs: Marialuisa Lavitrano & Elke Smits
Speakers:
Stefanie Houwaart
Sophia Turner | Is a Good Biobank an Empty Biobank?

12:00 - 13:30
10B: Population Biobanks – What Can We Learn from Large Cohort Studies in Diverse Populations?

Revealing the impact of different lifestyles, environments and genetic predispositions in diverse populations can help to improve disease prevention, risk prediction, and precision medicine. A fundamental role is played by prospective biobank studies that thoroughly characterize large numbers of healthy individuals and monitor their health/disease status over time. Success stories, pitfalls, and opportunities will be highlighted while emphasizing international collaborations to bring population-based biobanking to the next level.
Session Chairs: Dr Constantinos Deltas & Laurent Dollé
Speakers: Nahla Afifi

12:00 - 13:30
10C: Biobanks Driving Artificial Intelligence for a Healthier World

The amount of data we collect, generate and store is rapidly increasing due to new technologies (genomics, proteomics, etc.) that produce big data along with the large population cohorts, and global collaborations. In this session, we aim to highlight cohorts that generate big data, the methods/techniques (including but not limited to artificial intelligence) used to analyze the big data associated with these studies as well as concepts on how biobanks can either support or benefit from artificial intelligence.
Session Chair: Petr Holub

12:00 - 13:30
10D: Becoming a Biobanker: Yes We Can!

Becoming a Biobanker is dedicated to showcasing educational programs and courses for biobankers. Understand which international or European courses are being offered and discuss challenges and opportunities in a biobanker’s career.
Session Chairs: Tobias Sjöblom & Maimuna Mendy
Speakers:
Karine Sargsyan

13:30 - 14:00
Awards and Closing Ceremony
14:00 - 14:30
Coffee Break
15:00 - 16:30
Sightseeing Tour Lübeck*

Do you want to travel through time and listen to stories? Guides, dressed in historical costumes, talk about the customs and traditions of their time: either the middle ages or the 19th century. Come and experience Lübeck’s charm, join us on our walk to the city’s sights on the island of the old town, which measures about two square kilometres.

We will visit the world-famous medieval buildings from Lübeck’s heyday as the queen of the Hanseatic League – the Holsten Gate, St. Mary’s church or the Buddenbrook house.

Registration is required. The EBW2019 Steering Committee reserves the right to cancel the tour(s) if registrations do not reach the minimum required number.

15:30 - 18:30
Patient Information Symposium (in German)*
Select date to see events.
*Pre-registration is mandatory and additional fees might apply. Slots are limited and offered on a first-come, first served basis.
**Pre-registration is mandatory. Slots are limited and offered on a first-come, first served basis.
***Pre-registration is mandatory.
Close Menu